Boosting Open-Label Placebo Effects in Acute Induced Pain in Healthy Adults

NARecruitingINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Acute Pain
Interventions
PROCEDURE

OLP-injection

Open-label placebo injections without any active ingredient (5 ml 0.9% saline). All participants will be informed that the administered injections are placebo infusions.

OTHER

Scripted Evidence-based treatment rationale

As a second component the intervention will consist of an evidence-based treatment rationale, which will be delivered to patients receiving the intervention prior to the OLP-injections, explaining placebo analgesia in pain in general and specifically in OLP. In the context of OLP treatments this rationale is important in order to create a mental state of positive expectations.

OTHER

Experimental model of acute pain

Experimental model of acute pain (simulating wound pain: this installation will apply monophasic, rectangular electrical pulses of 0.5ms duration with alternating polarity at 2 Hz frequency. The current will be increased to target a pain rating of 6 of 10 on the NRS (0 = no pain, 10 = worst imaginable pain). Three further adjustments in current will be made every 5 minutes for the next 15 minutes to compensate for habituation. This final current will be kept constant until the end of the particular experiment).

Trial Locations (1)

4031

RECRUITING

University Hospital of Basel (USB); Department of Anaesthesiology, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER